January 24, 2017
ION Solutions to Provide Patient Engagement Technology to its Nationwide Oncology Network with HealthGrid
Frisco, Texas -- ION Solutions, a part of AmerisourceBergen and the largest physician service organization and group purchasing organization (GPO) specializing in the support of community oncology, and Orlando-based patient engagement company, HealthGrid, today announced a partnership to deliver a best-in-class patient engagement platform for community oncologists. The platform, powered by HealthGrid technology, will allow ION members who dispense and administer oral chemotherapy to connect with patients anytime, anywhere and through any mobile device. The tool will provide practices with actionable reminders, surveys, education and notifications to increase patient connectivity and improve medication adherence.
“ION Solutions is committed to providing community oncologists with critical resources that will better allow them to deliver exceptional patient care,” said Mark Santos, RPh, president of ION GPO. “We are excited to partner with HealthGrid to offer our members an advanced solution that will enhance patient engagement by improving access to critical health information and care management.”
As more patients begin to use self-administered oral medications, it has become increasingly important to enhance the connectivity and communication between the provider and patient. By offering this newest engagement platform to the largest network of dispensing practices, ION Solutions and HealthGrid have established a solution to ensure community oncologists stay connected with their patients even outside the four walls of the medical practice or pharmacy.
“Creating a patient engagement ecosystem is a critical part of cancer care, and HealthGrid is proud to bring intelligent patient engagement capabilities to ION’s network of providers,” said Raj Toleti, co-founder and CEO of HealthGrid. “When a patient-centered care delivery model for oncology care management is in place, the entire care process is more effective, and ultimately drives a better patient experience and improved outcomes.”
HealthGrid offers the first patient engagement customer relationship management (CRM) platform to help providers activate, acquire and retain patients while simultaneously complying with demanding regulatory requirements such as Meaningful Use and Medicare’s Merit-Based Incentive Payment System (MIPS). For more information on HealthGrid’s patient engagement solutions and its CRM platform, visit www.healthgrid.com.
About ION Solutions and AmerisourceBergen
ION Solutions, a part of AmerisourceBergen Corporation, is the largest physician service organization and GPO specializing in the support of community oncology. ION provides GPO procurement services, technologies, advocacy resources and expertise to more than half of the community-based oncology practices in the nation to help improve their clinical and operational management. For more information, go to www.iononline.com.
AmerisourceBergen is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health. With over $140 billion in annual revenue, AmerisourceBergen is headquartered in Valley Forge, PA, and employs approximately 19,000 people. AmerisourceBergen is ranked #12 on the Fortune 500 list. For more information, go to www.amerisourcebergen.com.
HealthGrid is shifting the patient experience paradigm - meeting patients where they are. Our mobile-first CRM platform is the industry leading patient engagement solution that enables providers to engage and activate patients at any point in the care continuum. For more information, visit www.healthgrid.com or connect on Twitter, Facebook, or Linkedin.